Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2026-02-22 @ 2:37 AM
Study NCT ID:
NCT03830918
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-14
First Post:
2019-02-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy
Sponsor:
Jonsson Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-06
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-01-03
Completion Date Type:
ESTIMATED
First Submit Date:
2019-02-04
First Submit QC Date:
None
Study First Post Date:
2019-02-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-12
Last Update Post Date:
2025-11-14
Last Update Post Date Type:
ESTIMATED